Abstract:Background: Elevated production of reactive oxygen species (ROS) and an altered redox state have frequently been observed in hepatocellular carcinoma (HCC); therefore, selective killing of HCC cells by chemotherapeutic agents that stimulate ROS generation or impair antioxidant systems may be a feasible approach in HCC chemotherapy. Recently, betulinic acid and its derivatives have attracted attention because they showed anti-cancer effects via a ROS-and mitochondria-related mechanism. However, the source of ROS overproduction and the role of mitochondria were poorly identified, and the weak in vivo antitumour activity of these compounds limits their development as drugs.Methods: Cytotoxicity was detected using MTT assays. In vivo anti-HCC effects were assessed using nude mice bearing HepG2 tumour xenografts. Cell cycle analysis, apoptosis rate and mitochondrial membrane potential were measured by flow cytometry. ROS production was detected using a microplate reader or a fluorescence microscope. Changes in gene and protein levels were measured by RT-PCR and western blotting, respectively. Other assays were performed using related detection kits.Results: B5G9, a piperazidine derivative of 23-hydroxy betulinic acid (23-HBA), showed excellent in vivo anti-HCC effects, with a tumour growth inhibitory rate of greater than 80%, and no significant side effects. B5G9 stimulated the production of ROS, which were derived from the mitochondria, but it had no effect on various other antioxidant systems. Moreover, B5G9 induced mitochondrial dysfunction, which was characterized by morphological changes, membrane potential collapse, membrane permeabilization, and decreases in the O-2 consumption rate and ATP production. Furthermore, mtDNA-depleted rho 0 HepG2 cells were less sensitive to B5G9 treatment than wt HepG2 cells, indicating the importance of mitochondria in B5G9-induced cell death.Conclusion: We discovered a piperazidine derivative of 23-HBA, B5G9, with excellent anti-HCC effects both in vivo and in vitro and no obvious toxic effects. The underlying mechanism was associated with mitochondria-derived ROS overproduction, and mitochondria played essential roles in B5G9-induced cell death. This study identified a potential agent for anti-HCC therapy and elucidated the mitochondria-related mechanism of BA and its derivatives.

Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway

Myricetin Induces Apoptosis In Hepg2 Cells Through Akt/P70s6k/Bad Signaling And Mitochondrial Apoptotic Pathway

Hernandezine induces autophagic cell death in human pancreatic cancer cells via activation of the ROS/AMPK signaling pathway

Hernandezine promotes cancer cell apoptosis and disrupts the lysosomal acidic environment and cathepsin D maturation

Astilbotriterpenic acid induces growth arrest and apoptosis in HeLa cells through mitochondria-related pathways and reactive oxygen species (ROS) production.

16-O-caffeoyl-16-hydroxylhexadecanoic Acid, a Medicinal Plant-Derived Phenylpropanoid, Induces Apoptosis in Human Hepatocarcinoma Cells Through ROS-dependent Endoplasmic Reticulum Stress.

Mitochondrial Pathway Mediated by Reactive Oxygen Species Involvement in Α-Hederin-induced Apoptosis in Hepatocellular Carcinoma Cells.

Hesperetin Induces Apoptosis of Esophageal Cancer Cells Via Mitochondrial Pathway Mediated by the Increased Intracellular Reactive Oxygen Species

Fruiting body polysaccharides of Hericium erinaceus induce apoptosis in human colorectal cancer cells via ROS generation mediating caspase-9-dependent signaling pathways.

Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway

Induction of Apoptosis in Human Hepatocellular Carcinoma Cells by Erianin Involves a Mitochondria-Mediated Pathway

Harmine Induces Apoptosis in HepG2 Cells Via Mitochondrial Signaling Pathway

Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.

Hellebrigenin Induces Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells Through Inhibition of Akt

A Piperazidine Derivative of 23-Hydroxy Betulinic Acid Induces a Mitochondria-Derived ROS Burst to Trigger Apoptotic Cell Death in Hepatocellular Carcinoma Cells.

Hericium erinaceus enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells

Pro-apoptotic Effects of Tectorigenin on Human Hepatocellular Carcinoma HepG2 Cells

Reactive Oxygen Species-Mitochondria Pathway Involved in LYG-202-induced Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells

Dihydromyricetin Induces Mitochondria-Mediated Apoptosis in HepG2 Cells Through Down-Regulation of the Akt/Bad Pathway.

Apigetrin Promotes TNFα-Induced Apoptosis, Necroptosis, G2/M Phase Cell Cycle Arrest, and ROS Generation through Inhibition of NF-κB Pathway in Hep3B Liver Cancer Cells

Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking